News related to Tasigna (Nilotinib) and/or conditions it is approved for
Dasatinib, a leukemia drug, has the potential to treat many cancers
Source: Breast Cancer News From Medical News Today [2014.08.21]
A leukemia drug called dasatinib shows promise for treating skin, breast and several other cancers, according to researchers at Loyola University Chicago Stritch School of Medicine.
Blueprint for the next generation of chronic myeloid leukemia treatment
Source: Cancer / Oncology News From Medical News Today [2014.08.21]
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have identified and characterized mutated forms of the gene that encodes BCR-ABL, the unregulated enzyme driving the blood...
Multiplying immune-system cells to battle pediatric leukemia
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.08.21]
Researchers at Children's Hospital Los Angeles have shown that a select team of immune-system cells from patients with leukemia can be multiplied in the lab, creating an army of natural killer cells...
Major breakthrough in the understanding of leukemia
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.08.15]
Scientists from Queen Mary University of London (QMUL) have discovered mutations in genes that lead to childhood leukaemia of the acute lymphoblastic type - the most common childhood cancer in the...
High risk of leukemia in Down syndrome: behind the scenes of genetics
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.08.11]
Children affected by trisomy 21 (or Down syndrome) are 50 to 500 times more likely to develop leukemia than other children.
Thiopurines used to treat inflammatory bowel disease could increase leukemia risk
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.08.09]
Immunosuppressive drugs called thiopurines have been found to increase the risk of myeloid disorders, such as acute myeloid leukemia and myelodysplastic syndrome, a rare bone marrow disorder...
Advanced genetic scanning techniques identify drug target for pediatric T-cell acute lymphoblastic leukemia
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.08.04]
In what is believed to be the largest genetic analysis of what triggers and propels progression of tumor growth in a common childhood blood cancer, researchers at NYU Langone Medical Center report...
'New drug target for leukemia identified'
Source: Blood / Hematology News From Medical News Today [2014.07.31]
The largest ever genetic analysis of childhood blood cancer has unveiled a strand of RNA that could be targeted by drugs to slow progression of leukemia.
FDA Expands Use of Imbruvica for Form of Leukemia
Source: MedicineNet Leukemia Specialty [2014.07.29]
Title: FDA Expands Use of Imbruvica for Form of Leukemia
Category: Health News
Created: 7/28/2014 4:35:00 PM
Last Editorial Review: 7/29/2014 12:00:00 AM
Volasertib Phase II data published including new overall survival results in older patients with acute myeloid leukemia
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.07.10]
Results from a Phase II study that compared volasertib plus low-dose cytarabine (LDAC), a form of chemotherapy, versus LDAC alone in older patients with untreated acute myeloid leukemia (AML) were...
Many Childhood Leukemia Survivors Aren't Taking 'Maintenance' Meds: Study
Source: MedicineNet Leukemia Specialty [2014.06.09]
Title: Many Childhood Leukemia Survivors Aren't Taking 'Maintenance' Meds: Study
Category: Health News
Created: 6/6/2014 12:35:00 PM
Last Editorial Review: 6/9/2014 12:00:00 AM
Nonadherence to leukemia maintenance medication in childhood triples relapse risk
Source: Compliance News From Medical News Today [2014.06.04]
An estimated 25 percent of children in remission from acute lymphocytic leukemia (ALL) are missing too many doses of an essential maintenance medication that minimizes their risk of relapse...
Source: MedicineNet Bladder Cancer Specialty [2014.05.08]
Category: Diseases and Conditions
Created: 8/2/2013 2:36:00 PM
Last Editorial Review: 5/8/2014 12:00:00 AM
New Drug Combo Might Help Older, Sicker Patients With Leukemia
Source: MedicineNet rituximab Specialty [2014.01.10]
Title: New Drug Combo Might Help Older, Sicker Patients With Leukemia
Category: Health News
Created: 1/9/2014 2:35:00 PM
Last Editorial Review: 1/10/2014 12:00:00 AM
New benchmark study of unrelated bone marrow transplantation for leukemia
Source: The Doctors Lounge - Hematology
Researchers at the University of Minnesota led the largest study to date in patients with leukemia undergoing bone marrow transplantation from unrelated donors.
CLL's 'Very Unusual Year'
Source: Medscape Hematology-Oncology Headlines [2014.08.20]
Dr. Bruce Cheson discusses how to choose among the new, exciting options available for the treatment of chronic lymphocytic leukemia: obinutuzumab, ibrutinib, and idelalisib.